(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PHARMACOBIO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

PHARMACOBIO

ST13

US500000079404073

Class

5

Filing

79404073

Registration

7998387

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

05/29/2026

Trademark type

Combined

Nice classes

5

Filing date

07/18/2024

Registration date

10/28/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/28/2025

Last transaction

05/29/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

KR

Examiner

SOMERVILLE, ARETHA CHARESE

Law office

L70

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the wording PHARMACOBIO with a stylized curved wave design.

Holders and representatives

Holders

PHARMACOBIO, INC.

Representatives

Kisuk Lee Harness, Dickey & Pierce, PLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Crude medicinesmedical herbs; dietary supplements; dietary and nutritional supplements; plant and herb extracts for medicinal purposesother than essential oils; nutraceuticals for the treatment of hair losscognitive declineinflammatory bowel disease; vaccines preparations; vitamin and mineral supplements; chemico-pharmaceutical preparations for the treatment of hair losscognitive declineinflammatory bowel disease; biological preparations for medical or veterinary purposes for the treatment of hair losscognitive declineinflammatory bowel disease; pharmaceutical preparations for the treatment of hair losscognitive declineinflammatory bowel disease

Publications

History of USPTO decisions and trademark events.

29 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/28/2026

FICS

FINAL DISPOSITION NOTICE SENT TO IB

05/09/2026

FIMP

FINAL DISPOSITION PROCESSED

05/09/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

02/26/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

02/11/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

02/11/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/28/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/28/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

10/28/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/09/2025

PUBO

PUBLISHED FOR OPPOSITION

09/09/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/03/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/08/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/14/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/14/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/14/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/14/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/14/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/14/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/14/2025

RFNT

REFUSAL PROCESSED BY IB

05/04/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

04/11/2025

RFRR

REFUSAL PROCESSED BY MPU

04/11/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/06/2025

CNRT

NON-FINAL ACTION WRITTEN

03/05/2025

DOCK

ASSIGNED TO EXAMINER

01/06/2025

MAFR

APPLICATION FILING RECEIPT MAILED

09/12/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/12/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

09/12/2024

Continuous trademark protection

Get notified about every new filing that threatens PHARMACOBIO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.